Concepedia

Amparo Ruiz Simón

AR

Statistics

Publications

2

Citations

663

H-Index

2

Active since

2015

Affiliations

Curtin University(Current)

Amparo Ruiz Simón is an author at Curtin University specializing in oncology, medicine, and adjuvant therapy.

Publications per year

2015–2017

2

Publications

2

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Miguel Martín, Amparo Ruiz Simón, Manuel Ruíz Borrego et al. · Journal of Clinical Oncology · 2015 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–2 of 2